These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33888337)

  • 1. The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix.
    Pei X; Xiang L; Chen W; Jiang W; Yin L; Shen X; Zhou X; Yang H
    Gynecol Oncol; 2021 Jun; 161(3):779-786. PubMed ID: 33888337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.
    Xing D; Zheng G; Schoolmeester JK; Li Z; Pallavajjala A; Haley L; Conner MG; Vang R; Hung CF; Wu TC; Ronnett BM
    Am J Surg Pathol; 2018 Jun; 42(6):750-760. PubMed ID: 29505425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression of SOX2 and HR-HPV RISH predicts poor prognosis in small cell neuroendocrine carcinoma of the uterine cervix.
    Zhang SW; Luo RZ; Sun XY; Yang X; Yang HX; Xiong SP; Liu LL
    BMC Cancer; 2021 Mar; 21(1):332. PubMed ID: 33789601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervix.
    Pan B; Yan S; Yuan L; Xiang H; Ju M; Xu S; Jia W; Li J; Zhao Q; Zheng M
    J Pathol; 2024 Jul; 263(3):372-385. PubMed ID: 38721894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
    Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative genomics of high grade neuroendocrine carcinoma of the cervix.
    Hillman RT; Cardnell R; Fujimoto J; Lee WC; Zhang J; Byers LA; Ramalingam P; Leitao M; Swisher E; Futreal PA; Frumovitz M
    PLoS One; 2020; 15(6):e0234505. PubMed ID: 32544169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer.
    Frumovitz M; Burzawa JK; Byers LA; Lyons YA; Ramalingam P; Coleman RL; Brown J
    Gynecol Oncol; 2016 Jun; 141(3):588-591. PubMed ID: 27079212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational profiles of marker genes of cervical carcinoma in Bangladeshi patients.
    Sharmin S; Zohura FT; Islam MS; Shimonty A; Khan MA; Parveen R; Sharmin F; Ahsan CR; Islam ABMMK; Yasmin M
    BMC Cancer; 2021 Mar; 21(1):289. PubMed ID: 33736612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.
    Lee SW; Lim KT; Bae DS; Park SY; Kim YT; Kim KR; Nam JH
    Gynecol Obstet Invest; 2015; 79(3):172-8. PubMed ID: 25500455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma.
    Lee HK; Kwon MJ; Ra YJ; Lee HS; Kim HS; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Min KW; Kang SY
    Diagn Pathol; 2020 Oct; 15(1):126. PubMed ID: 33054840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
    Feng M; Zou J; Zhang Y; Sun L
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
    [No Abstract]   [Full Text] [Related]  

  • 12. Small cell neuroendocrine carcinomas of the uterine cervix: a histological, immunohistochemical, and molecular genetic study.
    Ishida GM; Kato N; Hayasaka T; Saito M; Kobayashi H; Katayama Y; Sasou S; Yaegashi N; Kurachi H; Motoyama T
    Int J Gynecol Pathol; 2004 Oct; 23(4):366-72. PubMed ID: 15381906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and treatment comparison in small cell neuroendocrine carcinoma of the uterine cervix based on population analyses.
    Lin LM; Lin Q; Liu J; Chu KX; Huang YX; Zhang ZK; Li T; Dai YQ; Li JL
    Cancer Med; 2020 Sep; 9(18):6524-6532. PubMed ID: 32705800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIK3CA mutation and CNV status and post-chemoradiotherapy survival in patients with cervical cancer.
    Martell K; McIntyre JB; Kornaga EN; Chan AMY; Phan T; Köbel M; Enwere EK; Dean ML; Ghatage P; Lees-Miller SP; Doll CM
    Gynecol Oncol; 2020 Sep; 158(3):776-784. PubMed ID: 32653099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Profiling Reveals Limited Targetable Biomarkers in Neuroendocrine Carcinoma of the Cervix.
    Cimic A; Vranic S; Arguello D; Contreras E; Gatalica Z; Swensen J
    Appl Immunohistochem Mol Morphol; 2021 Apr; 29(4):299-304. PubMed ID: 33208671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
    Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
    Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study.
    Lee SW; Nam JH; Kim DY; Kim JH; Kim KR; Kim YM; Kim YT
    Int J Gynecol Cancer; 2010 Apr; 20(3):411-6. PubMed ID: 20375806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological characteristics and outcome of patients with small cell neuroendocrine carcinoma of the uterine cervix: case series and literature review.
    Wang Y; Mei K; Xiang MF; Li JM; Xie RM
    Eur J Gynaecol Oncol; 2013; 34(4):307-10. PubMed ID: 24020135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review.
    Nagao S; Miwa M; Maeda N; Kogiku A; Yamamoto K; Morimoto A; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Sakuma T; Fujiwara K
    Int J Gynecol Cancer; 2015 Sep; 25(7):1300-5. PubMed ID: 26166556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.
    Wright AA; Howitt BE; Myers AP; Dahlberg SE; Palescandolo E; Van Hummelen P; MacConaill LE; Shoni M; Wagle N; Jones RT; Quick CM; Laury A; Katz IT; Hahn WC; Matulonis UA; Hirsch MS
    Cancer; 2013 Nov; 119(21):3776-83. PubMed ID: 24037752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.